Casey Group's asthma new drug officially launched in China commercial market.

date
13/09/2025
Casey Group announced that the company's independently developed ultra-fine particle ICS/LABA dry powder inhaler Erye Chang Yi Yue Da has officially launched in China, providing a new treatment option for asthma patients, and will improve the convenience and accessibility of asthma treatment through multiple channels such as retail pharmacies and e-commerce platforms.